- Vouliez-vous dire
- pathogenicity, vaccines
Résultats de la recherche - 48 results
M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.
Cellular Influenza A Virus, H3N2 Subtype Influenza Vaccines Influenza, Human Lung mice Myeloid Differentiation Factor 88 Orthomyxoviridae Infections Rna Signal Transduction Th1 Cells Vaccination Vaccines ...
Comparative evaluation of live marker vaccine candidates "CP7_E2alf" and "flc11" along with C-strain "Riems" after oral vaccination.
vaccines show restrictions either in terms of marker capacities or immunogenicity. Recent research efforts were therefore directed at the design of new modified live marker vaccines. Among the most promising ...
Immunogenicity of eight Mycobacterium avium subsp. paratuberculosis specific antigens in DNA vaccinated and Map infected mice.
diagnostic tools and vaccines. Here we report on the immunogenicity of eight Map specific antigens, i.e. MAP1693 c, Ag3, MAP2677 c (identified by post-genomic and immunoproteomic analysis of Map secretome) and ...
Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines.
promising candidate of the five rpf-like proteins of Mtb in terms of its immunogenicity and protective efficacy and warrants further analysis for inclusion as an antigen in novel TB vaccines. Health Topics: ...
Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study36521
about vaccination. There are few data concerning the immunogenicity or the security of the adjuvanted-A/ H1N1 vaccine in transplanted and hemodialyzed patients. DESIGN, SETTING, PARTICIPANTS, & ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Keywords: clinical efficacy immunogenicity prophylactic HPV vaccines Abstract: This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the immunogenicity, ...
Immunogenicity of an adjuvanted 2009 pandemic influenza A (H1N1) vaccine in haemodialysed patients
prompted an urgent worldwide vaccination campaign, especially of high-risk subjects, such as maintenance haemodialysis (HD) patients. Still the immunogenicity of the pandemic A (H1N1) vaccine in HD patients ...
Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective.
reminded us once again of the need for a universal influenza vaccine that can elicit heterosubtypic protection. Here, we show the superior immunogenicity and immunoprotective capacity of the full-length ...
Implementation over the past 20 years of the 3R's principle for batch release at the Scientific Institute of Public Health, Belgium (IPH).
been implemented for testing the immunogenicity of acellullar pertussis (aP) vaccines. At IPH, a further reduction in the number of laboratory animals used was obtained by limiting the potency testing on ...
Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs.
showed immunogenicity after oronasal administration in domestic pigs. In contrast to the C-strain, CP7E2 alf vaccine allowed the use of DIVA approaches in serological tests. This study confirms CP7E2 alf ...